Neogen Corporation (NEOG): Price and Financial Metrics

NEOG POWR Grades

• Growth is the dimension where NEOG ranks best; there it ranks ahead of 92.78% of US stocks.
• NEOG's strongest trending metric is Growth; it's been moving up over the last 177 days.
• NEOG ranks lowest in Stability; there it ranks in the 11th percentile.

NEOG Stock Summary

• NEOGEN CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 22.34% of US listed stocks.
• Price to trailing twelve month operating cash flow for NEOG is currently 48.25, higher than 92.91% of US stocks with positive operating cash flow.
• Revenue growth over the past 12 months for NEOGEN CORP comes in at 73.02%, a number that bests 93.63% of the US stocks we're tracking.
• Stocks that are quantitatively similar to NEOG, based on their financial statements, market capitalization, and price volatility, are GTX, HAYN, DOOR, DG, and HELE.
• NEOG's SEC filings can be seen here. And to visit NEOGEN CORP's official web site, go to www.neogen.com.

NEOG Valuation Summary

• NEOG's EV/EBIT ratio is 89.3; this is 603.15% higher than that of the median Healthcare stock.
• NEOG's price/earnings ratio has moved down 159.1 over the prior 243 months.

Below are key valuation metrics over time for NEOG.

NEOG Growth Metrics

Its 2 year cash and equivalents growth rate is now at -15.55%.
• Its year over year price growth rate is now at -29.08%.
• Its 2 year net cashflow from operations growth rate is now at -14.19%.

Over the past 52 months, NEOG's revenue has gone up $224,097,000.

The table below shows NEOG's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	630.719	-5.888	-16.23
2022-09-30	531.203	30.685	36.439
2022-06-30	527.159	68.038	48.307
2022-03-31	514.491	69.617	49.108
2021-12-31	502.956	74.622	57.042
2021-09-30	487.439	79.165	62.099

NEOG's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NEOG has a Quality Grade of C, ranking ahead of 68.43% of graded US stocks.
• NEOG's asset turnover comes in at 0.545 -- ranking 74th of 680 Pharmaceutical Products stocks.
• UTHR, HSKA, and VNDA are the stocks whose asset turnover ratios are most correlated with NEOG.

The table below shows NEOG's key quality metrics over time.